TOTTORI UNIVERSITY HOSPITAL
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private, Subsidiary
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
31
Active:0
Completed:23
Trial Phases
3 Phases
Phase 2:1
Phase 4:7
Not Applicable:21
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (29 trials with phase data)• Click on a phase to view related trials
Not Applicable
21 (72.4%)Phase 4
7 (24.1%)Phase 2
1 (3.4%)Effects of Pioglitazone in Hypertensive Patients
- First Posted Date
- 2011-11-16
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- Tottori University Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT01472497
- Locations
- 🇯🇵
Tottori University Hospital, Yonago, Japan
Matrix Metalloproteinase (MMP) in Heart Failure
Completed
- Conditions
- Chronic Stable Heart Failure
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2011-07-21
- Lead Sponsor
- Tottori University Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT00663494
Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure
Phase 4
Completed
- Conditions
- Chronic Stable Heart Failure
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2008-04-22
- Lead Sponsor
- Tottori University Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT00663195
Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
Phase 4
Completed
- Conditions
- Chronic Stable Heart Failure
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2008-04-22
- Lead Sponsor
- Tottori University Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT00664222
Effects of Losartan on Insulin Resistance in Patients With Heart Failure
Phase 4
Completed
- Conditions
- Heart Failure
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2008-04-22
- Lead Sponsor
- Tottori University Hospital
- Target Recruit Count
- 16
- Registration Number
- NCT00663377
- Prev
- 1
- 2
- Next
News
No news found